SDAD1-AS1

Across TCGA pan-cancer cohorts, SDAD1-AS1 RNA differs between tumor and matched normal tissue in 11 of 18 cancer types tested, making tumor–normal expression one of SDAD1-AS1’s most consistent transcriptional readouts.

The strongest signal is observed in breast invasive carcinoma (BRCA), where SDAD1-AS1 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types SDAD1-AS1 is over-expressed in tumor, although a few such as THCA and KIRP show the opposite, repressed pattern.

BRCA, HNSC, and KIRC are the cancer types where SDAD1-AS1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in SDAD1-AS1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BRCA	All	All	+0.096	.003	6	view →
HNSC	All	II,III,IV	+0.023	.013	5	view →
KIRC	Male	All	+0.022	.008	5	view →
THCA	Female	II,III,IV	−0.042	.003	4	view →
KIRP	Male	All	−0.023	.017	4	view →
CHOL	All	All	+0.072	.004	2	view →
STAD	Male	All	+0.047	.033	2	view →
COAD	All	All	+0.036	.011	2	view →
LUSC	All	All	+0.028	.030	2	view →
LUAD	All	All	+0.113	.038	1	view →
LIHC	Female	All	+0.012	.048	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 11 strongest of 11 lineages.

SDAD1-AS1–BRCA

Open the BRCA breakdown →